Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 658.78 M645.13 M653.33 M653 M 2.61 B Research & development ———— — Operating income 215.31 M179.36 M157.4 M123.07 M 675.13 M Non-Operating Income, Total ———— — Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses ———— — Unusual income/expense ———— — Pretax income 215.44 M179.79 M158.09 M123.65 M 676.96 M Equity in earnings ———— — Taxes 51.71 M46.08 M37.97 M33.83 M 169.6 M Non-controlling/minority interest ———— — After tax other income/expense -1.78 M-1.18 M1.07 M-3.08 M -4.97 M Net income before discontinued operations 163.72 M133.7 M120.12 M89.83 M 507.37 M Discontinued operations ———— — Net income 163.72 M133.7 M120.12 M89.83 M 507.37 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 163.72 M133.7 M120.12 M89.83 M 507.37 M Basic earnings per share (Basic EPS) 1.731.371.230.93 5.26 Diluted earnings per share (Diluted EPS) 1.711.351.220.93 5.21 Average basic shares outstanding 94.81 M97.86 M97.67 M97.69 M — Diluted shares outstanding 95.58 M98.77 M98.72 M98.7 M — EBITDA 260.74 M219.31 M199.6 M165.69 M 845.34 M EBIT 216.47 M180.87 M158.86 M123.97 M 680.16 M Cost of revenue 1.41 B1.36 B1.35 B1.33 B 5.45 B Other cost of goods sold ———— — Depreciation & amortization (cash flow) 44.28 M38.44 M40.74 M41.72 M 165.18 M